← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Triterpenoid Therapeutics, Inc.
West Roxbury, MA
$1,349,702
Total funding
3
Grants
Funding over time
peak $649.7K · FY2019–22$1M$750K$500K$250K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$1,349,702 · 3
By mechanism
R43$949,702 · 2
N43$400,000 · 1
Investigators at Triterpenoid Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
TOPIC 430: A NEW SMALL MOLECULE SENOTHERAPEUTIC FOR THE CHEMOPREVENTION OF THERAPY-RELATED COGNITIVE AGING$400,000
N43 · FY2022 · CA
Development of the New Synthetic Triterpenoid CDDO-2P-IM (TTX01) for Glioblastoma$399,908
R43 · FY2020 · CA
Development of the New Synthetic Triterpenoid CDDO-2P-IM (TTX01) for Multiple Myeloma$299,995
R43 · FY2019 · CA
Development of the New Synthetic Triterpenoid CDDO-2P-Im for Chemoprevention of the ARDS of COVID-19$249,799
R43 · FY2020 · CA